SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-094719
Filing Date
2020-08-13
Accepted
2020-08-13 16:34:01
Documents
12
Period of Report
2020-08-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2027576-1_8k.htm   iXBRL 8-K 27707
  Complete submission text file 0001104659-20-094719.txt   206053

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20200811.xsd EX-101.SCH 3207
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20200811_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20200811_pre.xml EX-101.PRE 22724
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2027576-1_8k_htm.xml XML 3858
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 201099803
SIC: 2834 Pharmaceutical Preparations